Safety of Intravenous Neridronic Acid in CRPS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The aim of this trial was to investigate the safety of intravenous neridronic acid in patients with complex regional pain syndrome (CRPS). The trial was divided into 3 periods: a 60-day enrollment period, a treatment period consisting of 4 infusions over 10 days, and a follow-up period of approximately 50 weeks (with visits at Week 2, Week 6, Week 12, Week 26, Week 39, and Week 52).
Epistemonikos ID: 1f4ca0763730a59dac1aad133245c8fc1f1a1d27
First added on: May 20, 2024